Endomag
At Endomag, now a Hologic company, we believe everyone deserves a better standard of cancer care. That’s why we design our breast cancer localisation technologies with both the clinician and patient in mind.
Hospitals around the world use our unique solutions to help breast cancer patients avoid unnecessary surgery, and experience better outcomes when it is needed.
Our Sentimag® Gen 3 system, now with a thinner probe, pairs with the UK’s most-used localisation device, the Magseed® marker. It also identifies the Magtrace® lymphatic tracer, the world’s first non-radioactive dual tracer for SLNB, to create an unrivalled platform designed to support more surgical techniques.
Our technologies have already helped over 750,000 women worldwide to access more precise, and minimally invasive breast cancer treatment.
